Species Substitution in Herbal Raw Materials: What Your Certificate of Analysis Isn't Telling You

A 25-kg bag of ashwagandha root extract arrives at a supplement manufacturer’s facility in the Chicago suburbs. The supplier is reputable. The price is market-rate. The CoA checks every standard box: moisture, ash, heavy metals, withanolide assay. Everything looks fine — until an independent analytical testing laboratory runs HPTLC against a USP Withania somnifera reference standard and the chromatographic fingerprint doesn’t quite match. DNA barcoding confirms it: Withania coagulans, a closely related species with a different pharmacological profile, is present. The branded extract is not what it claims to be.

The supplier’s CoA was, in its own way, accurate. They never performed species authentication. And therein lies the problem.

The Supplier CoA Is a Document of Intent, Not a Guarantee

Most supplier certificates of analysis are generated from testing performed on a representative sample — sometimes from the batch, sometimes from a reference lot — covering a handful of parameters: moisture content, ash, heavy metals screen, basic microbiological panel, and perhaps a marker compound assay. What they almost never include, with the specificity a finished-goods manufacturer actually needs, is a definitive species-level botanical identity confirmation.

This isn’t necessarily negligence. Many raw material suppliers operate on thin margins with testing budgets calibrated to meet customer minimums, not to proactively catch substitution. The result is documentation that propagates forward through the supply chain, each link referencing the one before it, none of them performing independent re-verification.

By the time botanical material reaches a supplement brand in Illinois or Indiana, it may have passed through four or five intermediaries — each generating paperwork that looks authoritative and contains nothing about what’s actually in the material at a species level.

We’ve seen this pattern repeatedly. And it’s not limited to small or obscure botanicals. Turmeric, echinacea, milk thistle, valerian, ginkgo, ginseng, ashwagandha — these are high-volume, high-value botanicals with documented adulteration histories precisely because demand is large and supply-chain pressure is constant.

What Species Substitution Actually Looks Like in Practice

Botanical adulteration isn’t usually a deliberate fraud perpetrated by a single bad actor. More often, it enters the supply chain through a cascade of compounding oversights: a collector who harvests opportunistically when the target species is scarce, a processor who doesn’t authenticate what they receive, an intermediary who relies on the processor’s documentation, and a branded ingredient supplier who assumes their upstream partners did due diligence.

The American Botanical Council’s Botanical Adulterants Prevention Program has published detailed analyses across dozens of high-risk herbs. Their work, along with peer-reviewed studies in journals like PLOS ONE and Economic Botany, consistently finds that 20–30% of commercial herbal products show some form of identity or quality issue. For specific high-value botanicals the rate climbs higher.

Turmeric is a useful illustration. Curcumin is expensive. Synthetic curcumin analogs, synthetic colorants including Sudan dyes, and starch fillers are cheaper. Authentic Curcuma longa produces a characteristic ratio of curcuminoids: approximately 77% curcumin, 17% demethoxycurcumin, and 6% bisdemethoxycurcumin. A product spiked with synthetic curcumin skews heavily toward the primary compound, disrupting that ratio. Without HPLC alongside botanical identity testing, the discrepancy is invisible on a standard CoA.

Echinacea presents a different problem. Three species — E. purpurea, E. angustifolia, and E. pallida — are used commercially, but they have distinct phytochemical profiles and are not interchangeable in formulation. The ABC’s analyses found approximately 1 in 4 commercial echinacea products contained species other than what the label declared. Many of those products carried CoAs from suppliers.

HPTLC vs. DNA Barcoding: What Each Method Is Actually Catching

There’s genuine confusion in the supplement industry about which authentication method to specify. The honest answer is usually both — because they’re interrogating different dimensions of the same problem.

High-Performance Thin-Layer Chromatography (HPTLC) produces a chemical fingerprint by mapping the distribution of secondary metabolites — alkaloids, flavonoids, terpenes, phenolics — against an authenticated reference standard. USP <203> describes the framework; the USP Botanical Dietary Supplement monographs (now covering more than 80 herbs) provide reference chromatograms that serve as the gold standard for visual and densitometric comparison.

HPTLC catches adulterants that alter the chemical profile: wrong-species substitution where the chemistry differs, synthetic spiking, and significant dilution with inert material. It’s fast, cost-effective, and correlates directly with the chemical properties that matter to the finished product. Its limitation is that a very closely related species with a similar metabolite fingerprint can sometimes slip through.

DNA Barcoding sequences short, standardized regions of the chloroplast genome — typically rbcL, matK, or the ITS2 nuclear ribosomal region — and compares them against curated reference databases including GenBank and BOLD. Genetic sequencing definitively confirms or denies species identity at a level that chemistry cannot always achieve. An extract spiked with synthetic curcumin still carries the DNA of Curcuma longa. But an extract made from Curcuma zedoaria instead of C. longa will show a distinct sequence, even if the curcuminoid content looks normal.

DNA barcoding’s practical limitation is degradation. Highly processed extracts — spray-dried, standardized, or exposed to high heat — may have fragmented DNA that resists amplification. For those materials, HPTLC, HPLC, and isotope ratio analysis (which can distinguish plant-derived from synthetically produced compounds) carry the analytical weight.

For most raw material verification programs, the defensible approach pairs HPTLC with DNA barcoding on intact or lightly processed plant material, and leans on HPLC marker-compound profiling for standardized extracts. Our team applies all three approaches depending on the material form and its documented adulteration risk profile.

What 21 CFR Part 111 Requires — and What It Doesn’t Specify

The Dietary Supplement CGMPs rule (21 CFR Part 111) is unambiguous on one point: every manufacturer must establish the identity of each incoming raw material ingredient before it enters production. Specifically, §111.75(a)(1) requires at least one test or examination to verify the identity of each dietary ingredient component.

An FDA investigator who walks into a facility and finds the manufacturer relied entirely on a supplier CoA — without performing any independent identity verification — will issue a 483 observation under §111.75. We’ve seen it happen, and the citations are not difficult to contest when the underlying documentation is absent.

But here’s the important nuance that trips up a lot of quality teams: the regulation doesn’t mandate a specific method. It doesn’t require HPTLC. It doesn’t require DNA barcoding. It requires a test or examination adequate for the material. Some manufacturers use organoleptic testing — visual inspection, smell, taste — combined with macroscopic and microscopic analysis. For certain intact plant materials in a simple form, that may be technically sufficient.

For concentrated extracts, powders, or botanicals with documented adulteration histories, it is not. The FDA has issued warning letters to manufacturers whose identity testing lacked the specificity to distinguish adulterants in complex botanical materials. The adequacy standard scales with risk — and for high-value herbs with known substitution patterns, the bar is materially higher than a visual inspection.

DSHEA doesn’t offer a safe harbor simply because you conducted a test. The quality system must be adequate for the material in question. That’s a judgment call that should be made proactively, not after a recall forces the conversation.

Building a Raw Material Verification Protocol That Holds Up Under Scrutiny

A defensible incoming verification protocol for botanical raw materials typically operates across four tiers:

Tier 1 — Supplier Qualification Before First Purchase. Require any new supplier to document their identity testing methodology and the reference standard they test against. Three historical CoAs are a starting point; what matters is the underlying method. If a supplier can’t articulate how they verify species identity, that’s your answer.

Tier 2 — Independent Testing of Every Incoming Lot. No exceptions, no matter how long the supplier relationship. For every lot: HPTLC against a USP or authenticated reference standard at minimum. For standardized extracts, add HPLC marker-compound analysis. For botanicals on the high-risk list (echinacea, milk thistle, ashwagandha, turmeric, valerian, ginkgo, ginseng, elderberry), add DNA barcoding.

Tier 3 — Periodic Supplier Re-Qualification. Even approved suppliers experience supply chain pressure. Agricultural shortages, procurement changes, or price spikes can push substitution into the chain without any visible signal at the brand level. Annual re-qualification with blind sample submission to an independent analytical testing laboratory provides a meaningful safeguard.

Tier 4 — Documentation That Survives an FDA Inspection. Every test, every result, every anomaly, every release decision. If incoming testing produces an inconclusive or borderline result and you elect to release the lot, that decision and its rationale must be recorded, reviewed, and signed by qualified personnel. “It looked fine” is not a record.

One practical advantage for Chicago-area and Midwest manufacturers using a local sample-receiving hub: incoming lots spend 5–7 business days awaiting results rather than cycling through cross-country logistics. For brands managing tight production schedules, that turnaround isn’t a small thing.

The Cost Calculation Nobody Runs Until After a Recall

A comprehensive botanical identity panel — HPTLC plus DNA barcoding plus HPLC — for a single raw material lot typically runs between $400 and $900, depending on the material and analytical scope. On a 50-kg lot of ashwagandha extract at $80/kg, that’s a testing cost of roughly 10–20% of the ingredient value. It feels expensive in a QA budget review.

A Class II dietary supplement recall triggered by a misidentified botanical ingredient — the kind that involves retailer notification, consumer advisories, and FDA correspondence — costs brands an average of $10 million in direct costs according to enforcement data, before accounting for lost shelf space, retailer chargebacks, and the legal exposure that follows.

The math isn’t complicated. And yet, in our work with small and mid-sized brands across the Midwest, the incoming identity testing protocol is consistently among the first things cut when QA budgets tighten. It’s usually the same brands that later find themselves navigating a very different set of costs.

Supply chain pressure on high-demand botanicals isn’t easing. If anything, the conditions that make adulteration tempting — price volatility, agricultural disruption, concentrated overseas sourcing — have intensified over the past several years. The brands that navigate that environment without incident are the ones who’ve decided that raw material verification is a fixed cost of doing business, not a variable line item to be optimized away.

What your supplier’s CoA says and what’s in the bag are not always the same thing. Closing that gap is what analytical testing laboratories exist to do.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days. Contact us

Related from our network

• ISO 17025–accredited supplement testing for California and national brands — Qalitex Laboratories performs HPTLC, DNA barcoding, ICP-MS, and full USP microbiology panels under accredited scope for raw materials and finished dietary supplements.